VANCOUVER, Sept. 11, 2018
/CNW/ - Zecotek Photonics Inc.
("Zecotek" or the
"Company") (TSX-V: ZMS) (TSX-V: ZMS.V)
(Frankfurt: W1I) (OTCPK: ZMSPF), a developer of leading-edge
photonics technologies for healthcare, industrial and scientific
markets, is pleased to announce that it has shipped over
$225,000 worth of its patented LFS
scintillation crystals from recently announced orders. The initial
crystal shipments are for a new line of positron emission
tomography (PET) medical scanners.
"We have shipped over US$225,000
from recent orders of our patented LFS scintillation crystals for a
new line generation positron emission tomography medical scanners
and shipments will increase as the new facility in Shanghai ramps up crystal production," said
Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics
Inc. "I am very pleased with our progress towards becoming a
leading LFS crystal supplier in China and look forward as our manufacturing
capacity increases to take on the North American and European
markets."
Zecotek Imaging China, a subsidiary of Zecotek Imaging Systems
(Singapore), is commercializing
patented LFS scintillation crystals through its new production
facility in Shanghai, China.
Zecotek Imaging China is poised to become a leader in
large-scale production, cutting and polishing of scintillation
crystals grown by the Czochralski method in China. Using
a proprietary manufacturing process, very large-diameter boules
with uniform properties and without cracks are produced resulting
in high element output with lower unit costs.
The ISO certified LFS Crystal Production Facility has sufficient
capacity to meet the delivery schedule of our Tier 1 clients and
will be expanded to meet growing demand in late 2018 and early
2019.
The LFS series of scintillation crystals are known to be
uniquely qualified for components in PET medical scanners. LFS
crystals have the fastest decay parameter in their category, the
best energy resolution and competitive pricing, which are key
attributes for the new configurations of high resolution Time Of
Flight PET scanners. PET OEMs have conducted comparative tests with
other many other scintillation materials and recognize Zecotek's
LFS crystals to be superior for specific designs of PET medical
scanners.
Cutting, polishing and array assembly will also be done at the
production facility in Shanghai.
Zecotek has developed a proprietary automated manufacturing process
that uses robotics to assemble the LFS crystal arrays. The
automated process will translate into faster manufacturing of
arrays and improve the performance of the arrays with repeatable
uniformity and much greater accuracy.
Zecotek's LFS series of scintillation crystals are protected in
China and jurisdictions around
globe by a worldwide patent (including US patent No. 7,132,060).
The crystals cover a wide range of emission wavelengths which can
be tailored to match the spectral sensitivity of various photo
detectors including Zecotek's own solid-state MAPD/T photo detector
arrays.
Zecotek is focused on of becoming a leading supplier of
scintillation crystals and other key photonic components in
China and around the world.
About Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF) is a photonics
technology company developing high-performance scintillation
crystals, solid-state photo detectors, 3D displays and related
technologies for applications in medical, high-tech and industrial
sectors. Founded in 2004, Zecotek has three operating divisions:
Zecotek Imaging Systems, Zecotek Optronics Systems, and Zecotek
Autotronics with labs located in Canada, Korea, Russia, Singapore and U.S.A. It is commercializing over 55 patented
and patent pending novel photonic technologies directly and through
strategic alliances with the Shanghai EBO Optoelectronics
Technology Company (China),
Hamamatsu Photonics (Japan), the
European Organization for Nuclear Research (Switzerland), NuCare Medical Systems
(South Korea), the University of Washington (United States), and National NanoFab Center
(South Korea). For more
information visit www.zecotek.com and follow @zecotek on
Twitter.
This press release may contain forward-looking statements
that are based on management's expectations,
estimates, projections and assumptions. These statements are not
guarantees of future performance and involve certain risks and
uncertainties, which are difficult to predict. Therefore, actual
future results and trends may differ materially from what may have
been stated.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the content of this news release. If you would like to
receive news from Zecotek in the future, please visit the corporate
website at www.zecotek.com.
SOURCE Zecotek Photonics Inc
